logo
  Join        Login             Stock Quote

Radius Health Sets IPO Pricing Between $8.50 And $10.50

 October 22, 2012 09:55 AM


Radius Health Inc., a developer of therapies for osteoporosis and women's health, has set the terms for its initial public offering (IPO).

The Cambridge, Massachusetts-based company has launched an IPO of 6.5 million shares, with an estimated pricing between $8.50 and $10.50 apiece.

At the midpoint of the proposed range, Radius Health's will have an initial market capitalization of roughly $283 million. The company expects net proceeds from the offering to be roughly $55.8 million.

Radius has raised a total of $172.5 million from the following investors including:MPM Capital, HealthCare Ventures LLC, Brookside Capital and Oxford Bioscience Partners.

The company expect to use the net proceeds to fund the clinical development of its most advanced product candidates and for other general corporate purposes.

[Related -Sector Rotation Model Stays Bullish, But Neutral Rankings And Technical Resistance Flash Caution]

Radius Health's only product candidates are BA058, RAD1901 and RAD140, and none of these product candidates is approved by the FDA for sale, the company said in a regulatory filing.

For the 12 months ended December 2011, Radius Health posted a net loss of $42.5 million.

The company plans to list on the Nasdaq under the symbol "RDUS".

Radius Health has granted the underwriters a 30-day option to purchase up to an additional 975,000 shares to cover over-allotments.

UBS and Leerink Swann will be serving as co-lead underwriters.

iOnTheMarket Premium
Advertisement

Advertisement


Post Comment -- Login is required to post message
Name:  
Alert for new comments:
Your email:
Your Website:
Title:
Comments:
 

rss feed

Latest Stories

article imageSector Rotation Model Stays Bullish, But Neutral Rankings And Technical Resistance Flash Caution

Last week, stocks cycled bullish yet again. In fact, the S&P 500, NYSE Composite, and NASDAQ each closed at read on...

article image2000 More Points To Go?

15 years is a long time to wait for a 1%/yr read on...

article imageMixed Economic Signals So Far For The US In Q2

The outlook for first-quarter US growth has been cut to the bone, according to the current estimate of the read on...

article imageRetirees Will Need Some Income

There is more to retirement planning than “saving more” or “working read on...

Advertisement
Popular Articles

Advertisement
Daily Sector Scan
Partner Center

Related Articles:

Mixed Economic Signals So Far For The US In Q2
More Articles on: Medical



Fundamental data is provided by Zacks Investment Research, and Commentary, news and Press Releases provided by YellowBrix and Quotemedia.
All information provided "as is" for informational purposes only, not intended for trading purposes or advice. iStockAnalyst.com is not an investment adviser and does not provide, endorse or review any information or data contained herein.
The blog articles are opinions by respective blogger. By using this site you are agreeing to terms and conditions posted on respective bloggers' website.
The postings/comments on the site may or may not be from reliable sources. Neither iStockAnalyst nor any of its independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. You are solely responsible for the investment decisions made by you and the consequences resulting therefrom. By accessing the iStockAnalyst.com site, you agree not to redistribute the information found therein.
The sector scan is based on 15-30 minutes delayed data. The Pattern scan is based on EOD data.